Francesca Battaglin

11PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 17, 2026
Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer.

|Dec 21, 2025
Clinical and molecular characterization of AXL in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data.

Karam Ashouri, Joshua Millstein, Yan Yang

|Sep 04, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto

|Apr 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer.

Priya Jayachandran, Sachin K Deshmukh, Sharon Wu

|Nov 12, 2024
Clinical Applications of Circulating Tumor DNA Profiling in GI Cancers.

Francesca Battaglin, Heinz-Josef Lenz

|Aug 29, 2024
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review.

Karam Ashouri, Alexandra Wong, Pooja Mittal

Pageof 2

Frequent Collaborators

9 joint publications

Heinz-Josef Lenz

5 joint publications

Karam Ashouri

3 joint publications

Richard M Goldberg

3 joint publications

Sandra Algaze